ARCHIVES

Study Recommends Longer Courses Of Chemotherapy For Bone Marrow Cancer

This article is from The Cancer Letter archive.

Vol. 29 No. 3 | March 31, 2006

Download PDF Visit The Full Archive

Related Articles

Zometa Can Reduce Risk Of Skeletal-Related Events

August 26, 2011

University of Pittsburgh Cancer Institute Wins Core Grant Renewal

October 1, 2010

NTP Plans Look At Radiation, Viruses, In Carcinogen Report.

July 27, 2001

CMS, FDA Developing Process For Concurrent Therapy ApprovalsAACI To Honor Mary-Claire King, Sen. Sherrod Brown

October 1, 2010

Powers, NCI Still Disagree On Organ Systems Provisions

April 22, 1983

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

September 26, 1997